1 The study met its primary endpoint demonstrating a reduction in blood sugar (HbA 1c ) levels comparable with Toujeo and insulin degludec from baseline to week 24 (at a non-inferiority margin of 0.3% and difference between treatments of -0.05% [95% CI 0.15 to 0.05%])
Vomiting, constipation, and loose stools emerge as secondary gastrointestinal effects because altered stomach function cascades into changes throughout your entire digestive tract
This should always be discussed with your prescriber
Adam Schaffner, senior principal and director of insights Ipsos: Obefazimods positive Phase III induction data is a notable success for its novel mechanism
[38] LPL expression has been shown to be a prognostic predictor in Chronic lymphocytic leukemia
Research suggests that GLP-1 receptors are present not only in the pancreas and gastrointestinal tract but also in key brain regions involved in reward processing and food motivation, including the nucleus accumbens and ventral tegmental area, though much of this evidence comes from preclinical studies